Essentia Health Duluth Clinic RN Hypertension Management Pilot
|
|
- June Floyd
- 5 years ago
- Views:
Transcription
1 Hypertension Best Practices Symposium Sponsored by AMGA and Daiichi Sankyo, Inc. October 13-15, 2010 Scottsdale, AZ Essentia Health Duluth Clinic RN Hypertension Management Pilot 1
2 1888:St. Mary s Hospital founded 1915:Duluth Clinic established 1997:SMDC Health System launched with integration of St. Mary s and Duluth Clinic 2010: SMDC Health System, Innovis Health, Brainerd Lakes Health, and Essentia Community Hospitals and Clinics form integrated healthcare system called Essentia Health 400,000 + annual patient visits at the Duluth EMR: EPIC 2
3
4 Goals & Objectives Increase the percentage of patients with a diagnosis of hypertension and diabetes that have a BP < 130/80 Improve patient education, self-management skills and lifestyle choices associated with the management of hypertension 4
5 Why RN-Focused Management? Effective management of hypertension requires systematic and coordinated patient care management. A multidisciplinary team-based approach can influence and reinforce goals and ensure adherence. Literature supports RN participation in hypertension as a matter of course. It is not instead of physicians, but complementary. Research also demonstrated that RN management of HTN in collaboration with physician is superior in BP control to standard office-based management.
6 Population Baseline Patients ages who have concurrent diagnosis of Diabetes Mellitus ( Dx code )and hypertension Two Pilot Sites Identified from patient registry within EMR and physician referral 6
7 Improvement Interventions 1d/wk dedicated RN Care Management to work with two physician patient panels at each site. Established referral process with physicians Hypertension standing orders/medication management protocol Patient registry 7
8
9
10 Improvement Interventions Optimization of pharmacologic and non-pharmacologic therapies consistent with JNC 7: Shorten time between follow-up for pts Assess effectiveness of current medication regimen with ability to titrate dose and/or add medication per protocol Individualized patient education re: lifestyle modification
11 Assessment and Development of Treatment Plan Education of patients re: target blood pressure and the importance of achieving and maintaining this target. Self/home blood pressure monitoring techniques and appropriate equipment. (BP cuffs provided as $$ allowed) Identify lifestyle factors that influence hypertension management, recognize potential areas for change and create a collaborative management plan.
12 Lifestyle Interventions A combination of lifestyle interventions is often needed to achieve optimal blood pressure values Diet, weight, exercise, smoking, alcohol consumption and stress are lifestyle factors that impact on blood pressure. Some lifestyle interventions have the potential to decrease blood pressure levels to the equivalent of a half to one standard dose of an antihypertensive drug Example: For some individuals, a 1600 mg sodium DASH eating plan has BP effects similar to single drug therapy. (JNC 7)
13 Lifestyle Interventions Partner with patient to create My Change Plan with S.M.A.R.T goals Specific Measureable Attainable Realistic Timely Motivational Interviewing training for RN staff Referrals when appropriate (Weight Management, QuitPlan, Dietician) Assess adherence to medication (side effects, financial concerns, etc.)
14 Medication Titration Protocol designed for hypertensive pts with diabetes Initiate/titrate dose per algorithm Step 1: ACE Inhibitor Step 2: Add thiazide diuretic Step 3: Add dihydropyridine calcium channel blocker Each step in protocol includes required labs, follow-up intervals, contraindications, relative contraindications, cautions and guidance as to MD consultation All changes documented and provider informed
15 Measures Used National Institutes of Health (2003). The seventh report of the Joint National Committee: Prevention, detection, evaluation and treatment of high blood pressure. JNC 7. Institute for Clinical Systems Improvement (ICSI). Diagnosis and Management of Type 2 Diabetes Mellitus in Adults.14 th edition, July Institute for Clinical Systems Improvement (ICSI) Hypertension Diagnosis and Treatment. 12 th edition, October
16 Snapshot of RN-Managed Patient Cohort Essentia Health- Ashland Clinic :Site 1 n=55 Average age: 64 yrs 54% male 56% female 91% non-smokers 87% on daily ASA
17 Snapshot of RN-Managed Patient Cohort Average BMI = 35 All Patients n= 89,760 2% underweight (< 18.5) 1% 4% normal weight ( ) 25% 18% overweight ( ) 33% 29% Obese Class I ( ) 23% 22% Obese Class II ( ) 11% 25% Extreme Obesity (>=40) 7%
18 Snapshot of RN-Managed Patient Cohort Medication Management 0 Meds 4% 3 Meds 29% 1 Med 20% 4 Meds 13% 2 Meds 34% Drug Classification 71% patients on ACE 9% patients on ARB 33% patients on Calcium-channel blocker 49% patients on Beta-blocker 58% patients on diuretic
19 Challenges Time constraints, 8 hours per week Clear referral process Patients not fitting titration protocol Fragmented care between providers Multiple physicians (specialists) adjusting medications Reimbursement for RN visits the average unadjusted 2009 payment from Medicare for a service was $21. Ambivalence by patients. My blood pressure is fine. Engaging patients to follow through on lifestyle changes Medication confusion, adherence and cost Physician agreement with existing/evolving guidelines Obesity 19
20 Outcomes and Successes Key elements to success: Cooperative management with pilot physicians Follow- through and coaching Team work with ancillary staff PSA s who contacted and scheduled patients that were due for follow up. RN s who took opportunities at other appointment to check a BP CA s who took BP s and handled referrals Increased patient satisfaction 20
21 RN Managed Hypertension Pilot Site 1 and 2 October August Oct-09 Aug-10 Average Systolic/ Site 1 Average Systolic/Site 2 Average Diastolic/Site 1 Average Diastolic/Site 2
22 100 Percent of Patients Referred to RN- Managed HTN Pilot Program with BP < 130/80 Baseline - Current (August 2010) n= 107 % of patients in pilot group with BP < 130/ Site 1 n=55 Site 2 n=52 Site 1 & 2 n=107 10/1/2009 Baseline 8/1/2010 Current
23 Lessons Learned As confidence increases in medication titration and RN management we could anticipate increased improvement in outcomes Avoid missed opportunities to assess BP and modify treatment as appropriate Example: Pt calling for HTN med refill: Length of refill determined by pt meeting or not meeting tx goal Team approach essential It cannot all happen in a 15 minute MD appt Collaborate with pt to set goals Patients have ability to veto any advice as soon as they leave the clinic. 23
24 Future Steps More data needed to assess value of intervention. Improvement can be attributed to many different factors in place over last 6-9 months. Addition of pharmacist/medication Management 24
25 Questions Do you have any questions you d like to pose to the group? 25
26 Bibliography AHA/ADA Scientific Statement: Primary Prevention of Cardiovascular Diseases in People with Diabetes Mellitus American Heart Association Quick Reference Medication Table Canadian Hypertension Society (2004). The 2004 CHEP recommendations for the management of hypertension. Canadian Hypertension Education Program. Retrieved [Electronic Version] from Canadian Hypertension Society (2005). The 2005 Canadian Hypertension Education Program Recommendations. Retrieved [Electronic Version] from: Canadian Medical Association (1999). Lifestyle modifications to prevent and control hypertension. Canadian Medical Association Journal, 160(9 Suppl), S1-S50. Fonseca-Reyes, S., Garcia de Alba-Garcia, J., Parra-Carrillo, J., & Paczka-Zapata, J. (2003). Effect of standard cuff on blood pressure readings in patients with obese arms. How frequent are arms of a large circumference? Blood Pressure Monitoring, 8(3), Graves, J., Bailey, K., & Sheps, S. (2003). The changing distribution of arm circumferences in NHANES III and NHANES 2000 and its impact on the utility of the standard adult blood pressure cuff. Blood Pressure Monitoring, 8(6), Institute for Clinical Systems Improvement (ICSI).Diagnosis and Management of Type 2 Diabetes Mellitus in Adults.14th edition.july Institute for Clinical Systems Improvement (ICSI) Hypertension Diagnosis and Treatment. 12th edition. October National Institutes of Health (2003). The seventh report of the Joint National Committee: Prevention, detection, evaluation and treatment of high blood pressure. JNC 7. National Institutes of Health. Retrieved [Electronic Version] from Nurse Management for Hypertension: A Systems Approach. Rudd, et.al. American Journal of Hypertension Staged Diabetes Management: Prevention, Detection, and Treatment of Diabetes in Adults Quick Guide, 4th edition, IDC Up to Date/Drug Information Handbook. Lexi-Drugs. 14th edition Williams, B., Poulter, N., Brown, M., Davis, M., McInnes, G., Potter, J. et al. (2004). Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004 BHS IV. Journal of Human Hypertension, 18(3),
JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More informationHypertension Clinical case scenarios for primary care
Hypertension Clinical case scenarios for primary care Implementing NICE guidance August 2011 NICE clinical guideline 127 What this presentation covers Five clinical case scenarios, including: presentation
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationSummary of recommendations
Summary of recommendations Measuring blood pressure (BP) Use the recommended technique at every BP reading to ensure accurate measurements and avoid common errs. Pay particular attention to the following:
More informationNew Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets
New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More informationEffective Date: TBD Version: 1.0 (Revised: 6/11/2014)
Protocol Title: Hypertension Effective Date: TBD Version: 1.0 (Revised: 6/11/2014) Approval By: TBD Planned Review Date: TBD 1 Purpose & Objective This protocol provides evidence-based care recommendations
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationManaging Hypertension in 2016
Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationPreventing and Treating High Blood Pressure
Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationMODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk
MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationRenal Denervation. by Walead Latif, DO, MBA, CPE Assistant Clinical Professor Rutgers Medical School
Renal Denervation by Walead Latif, DO, MBA, CPE Assistant Clinical Professor Rutgers Medical School Disclosure Information ACOI Annual Meeting I have the following financial relationships to disclose:
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationRole of the Clinical Pharmacist in Primary Care
Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente
More informationPrevention of Heart Failure: What s New with Hypertension
Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults
More informationHypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg
Hypertension diagnosis (see detail document) Non-diabetic Diabetic Very elderly (older than 80 years) Target less than 140/90mmHg Target less than 130/80mmHg Consider SBP target less than 150mmHg Non-diabetic
More informationModern Management of Hypertension: Where Do We Draw the Line?
Modern Management of Hypertension: Where Do We Draw the Line? Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Blood Pressure
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationLayered Approaches to Studying Drug Responses
Layered Approaches to Studying Drug Responses Brian B Hoffman, MD Chief of Medicine VA Boston Health Care System Professor of Medicine Harvard Medical School Conflict of Interest: US Federal Grant Funding
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationManagement of High Blood Pressure in Adults
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management
More informationModern Management of Hypertension
Modern Management of Hypertension Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Hypertension Prevalence
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationHypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA
Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA Case 1 What should be your BP goal for an elderly (> 75 yrs of
More informationHTN talk_l Davis_ /28/2018
1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,
More informationPharmacological management of hypertension
LINIL GUIDNE Pharmacological management of hypertension ernard Higgins and ryan Williams, on behalf of the Guideline Development Group* (edited by Lynne Turner-Stokes) ernard Higgins FRP, Director, National
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationModule 3.2. Management of hypertension at primary health care
Module 3.2 Management of hypertension at primary health care What s inside Introduction Learning outcomes Topics covered Competency Teaching and learning activities Background information Introduction
More informationJNC-8. (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines
JNC-8 (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines Derrick Sorweide, DO Assistant Professor of Family Medicine,
More informationImplementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care
Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care Shari Bolen MD, MPH MetroHealth/Case Western Reserve University 1 Disclosure
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationTIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**
Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition ACOFP - The Heart of the Matter - An Evidence
More informationUpdate in Hypertension
Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded
More informationCHI Franciscan. Matt Levi Director Virtual Health Services. March 31, 2015
CHI Franciscan Matt Levi Director Virtual Health Services March 31, 2015 Reflection / 2 Agenda Introduction and background Matt Levi Director of Franciscan Health System Virtual Health Katie Farrell Manager
More informationMANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION
Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationJNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH
JNC 8 -Controversies Sagren Naidoo Nephrologist CMJAH Joint National Committee (JNC) Panel appointed by the National Heart, Lung, and Blood Institute (NHLBI) First guidelines (JNC-1) published in 1977
More informationDiabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
More informationEvolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)
Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina
More informationPlaying the Game: Strategies For Completing the ACO Measures
ACO Quality Scoring Playing the Game: Strategies For Completing the ACO Measures June 2, 2016 1 2 Quality Measure Score Primary Focus on: GPRO (Group Practice Reporting Option) Measures >50% Preventative
More informationPrimary hypertension in adults
Primary hypertension in adults NICE provided the content for this booklet which is independent of any company or product advertised Hypertension Welcome NICE published an updated guideline on the diagnosis
More informationThe Hypertension Clinic is a part of the Internal Medicine
Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationDisclosures. Learning Objectives. Hypertension: a sprint to the finish Ontario Pharmacists Association 1
Disclosures I have no current or past relationships with commercial entities I have received a speaker s fee from the Ontario Pharmacists Association for this learning activity Laura Tsang PharmD Sunnybrook
More informationHypertension. Penny Mosley MRPharmS
Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines
More informationHypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program
Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card
More informationManagement of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University
Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:
More informationManagement of Lipid Disorders and Hypertension: Implications of the New Guidelines
Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine
More informationDisclosures. Hypertension: Nationwide Dilemma. Learning Objectives. What s Currently Recommended? Specific Concerns 3/9/2012
How Should We ACCOMPLISH Good Blood Pressure Control In Our VETS? Disclosures No conflicts of interest to disclose Updates in the Management of HypertensionIn the Elderly Antoine T. Jenkins, Pharm.D.,
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationDr Doris M. W Kinuthia
Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of
More informationMeasure Up/Pressure Down Medical Group Success
Measure Up/Pressure Down Medical Group Success Deborah A. Molina, MPA, MBA Manager, Quality Jamie L. Reedy, MD, MPH Medical Director, Population Health Laura Balsamini, Pharm D, BCPS Director, Pharmacy
More informationWhat in the World is Functional Medicine?
What in the World is Functional Medicine? An Introduction to a Systems Based Approach of Chronic Disease Meneah R Haworth, FNP-C Disclosure v I am a student of the Institute for Functional Medicine. They
More informationCLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension.
GUIDELINE CLINICAL GUIDELINE Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension. TITLE Management of adult patients referred to South
More information2017 High Blood Pressure Clinical Practice Guideline
2017 High Blood Pressure Clinical Practice Guideline Applying the Latest Hypertension Guideline to Your Practice Carmine D Amico, D.O., F.A.C.C. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH /
More informationVolume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)
Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical
More informationHypertension Update Background
Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison
More informationYour Numbers Tell Your Story. Jennifer Stafford, RN Legacy Meridian Park Medical Center
Your Numbers Tell Your Story Jennifer Stafford, RN Legacy Meridian Park Medical Center One in three Americans has high BP. Thirty percent of those with high BP don t know they have it. Only half of those
More informationBlue Shield Participation
9 th Annual Right Care Initiative Summit Blue Shield Participation Scott Flinn, MD Regional Medical Director Blue Shield of California 1 Care Worthy of our Family and Friends 2 Bottom Line Up Front Blue
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationHypertension Update. Aaron J. Friedberg, MD
Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline
More informationText-based Document. Women are Different!: Gender Specific Protocols for Treatment of Hypertension. Authors Whiffen, Rebecca J.
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationManaging HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
More informationNew Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.
PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationAdapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017
Insert Logo or Org Name Here Primary Care Medical Directive for Hypertension Management Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017 Title:
More informationMonthly Campaign Webinar. May 19, 2016
Monthly Campaign Webinar May 19, 2016 WEBINAR REMINDERS Webinar will be recorded today and available the week of May 23 rd Together2Goal.org Website (Improve Patient Outcomes Webinars) Email distribution
More information} CHSI is working to identify the percentage of patients that are diagnosed with pre-diabetes.
} CHSI is working to identify the percentage of patients that are diagnosed with pre-diabetes. } Get all providers within the clinic to include the diagnosis in the problem list } Implement an evidenced
More informationCARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
More informationDifficult to Treat Hypertension
Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic
More informationFirst line treatment of primary hypertension
First line treatment of primary hypertension Dr. Vijaya Musini Assistant Professor, Dept. Anesthesiology, Pharmacology and Therapeutics Manager, Drug Assessment Working Group Therapeutics Initiative Editor,
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationHypertension Management: A Moving Target
9:45 :30am Hypertension Management: A Moving Target SPEAKER Karol Watson, MD, PhD, FACC Presenter Disclosure Information The following relationships exist related to this presentation: Karol E. Watson,
More informationNotes Indicate to the group that this patient will be the focus of today s case discussion.
1 Indicate to the group that this patient will be the focus of today s case discussion. Read out the case authors and their disclosure information. Instructions Fill out prior to the meeting and disclose
More informationThe New Hypertension Guidelines
The New Hypertension Guidelines Joseph Saseen, PharmD Professor and Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus Disclosure Joseph Saseen reports no conflicts
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationStrategies for Managing Hypertension
Strategies for Managing Hypertension by Marsha K. Millonig, MBA, RPh President,Catalyst Enterprises, LLC E.L.F. Publications, Inc. is accredited by the Accreditation Council for Pharmacy Education as a
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationPrimary Care Pharmacist Integration and Reimbursement Models
Primary Care Pharmacist Integration and Reimbursement Models May 20, 2015 MODERATOR: Marie Smith, PharmD Palmer Professor and Assistant Dean, Practice and Public Policy Partnerships, UConn School of Pharmacy
More informationDisclosures. Goals. Blood Pressure UPDATE ON HYPERTENSION: NM PEDS SOCIETY WYLDER LECTURES- CRAIG WONG MD AUG 28, 2016
Disclosures UPDATE ON HYPERTENSION: NM PEDS SOCIETY WYLDER LECTURES- CRAIG WONG MD AUG 28, 2016 Craig Wong MD MPH, Support from NIH: UO1 DK 066174 - CKiD RO1 DK 082394 -PediGFR UM1DK100866 - CureGN UpToDate:
More informationTobacco screening and follow-up if positive for tobacco use
1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 5 45 4 35 3 25 2 15 1 5 16 14 12 1 8 6 4 2 1.% 9. % 8. % 7. % 6. % 5. % 4. % 3. % 2. % 1. %. % 1
More informationBilling and Coding for Pediatric Obesity Care
Novick 1 Billing and Coding for Pediatric Obesity Care PA Medical Home Spring 2014 Conference on Pediatric Obesity May 25, 2014 Marsha B. Novick, MD Medical Director, Pediatric Multidisciplinary Weight
More informationOutcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension
Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension Prof. Massimo Volpe, MD, FAHA, FESC, Chair of Cardiology, Department of Clinical and Molecular Medicine
More informationUpdate on Current Trends in Hypertension Management
Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More information2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST
CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine
More informationAmerican Diabetes Association: Standards of Medical Care in Diabetes 2015
American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform
More information